Skip to main content

Table 2 Patient data

From: Preoperative C-reactive protein and other inflammatory markers as predictors of postoperative complications in patients with colorectal neoplasia

Patient demographics

Tumor data

Preoperative laboratory values

Postoperative complications

Clavien-Dindo grades

Variable

n

(%)

Variable

n

(%)

Variable

[s]

Variable

n

(%)

Variable

n

(%)

Age > 65

147

(67.4)

Tumor site

 

Hb (g/dL)

12.4

[2.1]

Ileus

13

(6.0)

No complications

111

(50.9)

Male

136

(62.4)

Rectum

49

(22.5)

WBC (× 109/L)

7.4

[2.2]

Wound infection

8

(3.7)

CD I

52

(23.9)

BMI ≥ 30

43

(29.9)

Left colon

90

(41.3)

Platelets (× 109/L)

273

[82.6]

Wound dehiscence

3

(1.4)

CD II

14

(6.4)

Patient comorbidity

Right colon

79

(36.2)

Neutrophils (× 109/L)

4.8

[1.9]

Hernia

7

(3.2)

CD III

12

(5.5)

Cardiovascular

65

(29.8)

Tumor stage T3/T4

120

(60.9)

Lymphocytes (× 109/L)

1.5

[0.6]

Anastomotic leak

6

(2.8)

CD IV

27

(12.4)

Respiratory

44

(20.2)

Node-positive

74

(37.6)

PLR

208

[125.2]

Sepsis

7

(3.2)

CD V

2

(0.9)

Renal

43

(19.7)

Malignant

198

(90.8)

NLR

4.0

[4.5]

Embolism

8

(3.7)

Diabetes

34

(15.6)

Moderately/poorly differentiated

192

(97)

CRP (mg/L)

18.7

[34.1]

Urinary

16

(7.3)

Autoimmune

31

(14.2)

CEA (ng/mL)

8.4

[24.7]

Renal

16

(7.3)

Smoker

30

(16.3)

Respiratory

25

(11.5)

Laparoscopic

176

(80.7)

Cardiovascular

21

(9.6)

Neurological

9

(4.1)

  1. mean, s standard deviation, Hb hemoglobin, WBC white blood cells, PLR platelet to lymphocyte ratio, NLR neutrophil to lymphocyte ratio, CRP C-reactive protein, CEA carcinoembryonic antigen, CD Clavien-Dindo